Cargando…
Clinical results with two different pharmaceutical preparations of riboflavin in corneal cross-linking: an 18-month follow up
BACKGROUND: Comparison of long-term clinical results of two different pharmaceutical formulations used in corneal cross-linking (CXL) in keratoconus patients. METHODS: Sixty eyes of 60 keratoconus patients underwent CXL in two groups. We used riboflavin preparations from Sina Darou, Iran in group A,...
Autores principales: | Hashemi, Hassan, Seyedian, Mohammad Amin, Miraftab, Mohammad, Bahrmandy, Hooman, Sabzevari, Araz, Asgari, Soheila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314761/ https://www.ncbi.nlm.nih.gov/pubmed/25616392 http://dx.doi.org/10.1186/s40199-015-0091-z |
Ejemplares similares
-
Comparison of clinical results of two pharmaceutical products of riboflavin in corneal collagen cross-linking for keratoconus
por: Hashemi, Hassan, et al.
Publicado: (2014) -
Corneal Collagen Cross-Linking in the Treatment of Progressive Keratoconus: A Randomized Controlled Contralateral Eye Study
por: Seyedian, Mohammad A., et al.
Publicado: (2015) -
Mesopic Quality of Vision after Accelerated 18 mW/cm(2) Corneal Cross-linking: Mid-term Results
por: Hashemi, Hassan, et al.
Publicado: (2017) -
Multipoint assessment of demarcation line depth after standard and accelerated cross-linking in central and inferior keratoconus
por: Asgari, Soheila, et al.
Publicado: (2018) -
Matched comparison of corneal higher order aberrations induced by SMILE to femtosecond assisted LASIK and to PRK in correcting moderate and high myopia: 3.00mm vs. 6.00mm
por: Miraftab, Mohammad, et al.
Publicado: (2021)